Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zacharenia Saridaki
Observed names:
Z Saridaki,
Z. Saridaki,
Zacharenia (Zenia) Saridaki,
Ζαχαρένια Σαριδάκη
Institution:
Metropolitan Hospital
Observed institutions:
University of Crete,
Alexandra Hospital,
Hellenic Oncology Research Group,
University Hospital of Heraklion,
Metropolitan Hospital,
Hellenic Society of Medical Oncology,
KU Leuven
show all 7
ORCID:
0000-0003-2931-5797
Observed ORCID:
0000-0003-2931-5797
OpenAlex ID:
A5012832857
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
2009
·
J Souglakos
, J Philips
, et al.
·
British Journal of Cancer
·
316
PDF
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
2009
·
Panayiotis A. Theodoropoulos
, Hara Polioudaki
, et al.
·
Cancer Letters
·
297
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
2014
·
D. Klingbiel
, Z. Saridaki
, et al.
·
Annals of Oncology
·
238
PDF
Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients
2011
·
Zacharenia Saridaki
, Maria Tzardi
, et al.
·
PLoS ONE
·
131
PDF
BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome
2010
·
Z Saridaki
, D Papadatos-Pastos
, et al.
·
British Journal of Cancer
·
116
PDF
Prognostic and predictive significance of MSI in stages II/III colon cancer
2014
·
Zacharenia Saridaki
, John Souglakos
, et al.
·
World Journal of Gastroenterology
·
89
PDF
Velour trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity.
2017
·
Pratyaksha Wirapati
, Valentina Pomella
, et al.
·
Journal of Clinical Oncology
·
57
BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients’ Outcome
2013
·
Zacharenia Saridaki
, Maria Tzardi
, et al.
·
PLoS ONE
·
57
PDF
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group
2020
·
Elena Fountzilas
, Georgia-Angeliki Koliou
, et al.
·
ESMO Open
·
48
Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group
2021
·
Helena Linardou
, Nikolaos Spanakis
, et al.
·
Cancers
·
39
PDF
VELOUR trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity
2017
·
Pratyaksha Wirapati
, Valentina Pomella
, et al.
·
Annals of Oncology
·
39
PDF
Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Study
2009
·
Charalambos Kouroussis
, Lambros Vamvakas
, et al.
·
Oncology
·
35
Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
2010
·
Zacharenia Saridaki
, Vassilis Georgoulias
, et al.
·
World Journal of Gastroenterology
·
34
PDF
Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status
2006
·
John Souglakos
, Lambros Vamvakas
, et al.
·
Breast Cancer Research
·
32
PDF
A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
2011
·
Zacharenia Saridaki
, Nikolaos Malamos
, et al.
·
Cancer Chemotherapy and Pharmacology
·
31
High Frequency of Loss of Heterozygosity on Chromosome Region 9p21–p22 but Lack of p16INK4a/p19ARF Mutations in Greek Patients with Basal Cell Carcinoma of the Skin
2000
·
Zacharenia Saridaki
, George Sourvinos
, et al.
·
Journal of Investigative Dermatology
·
26
PDF
Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer
2023
·
Elena Fountzilas
, Kyriaki Papadopoulou
, et al.
·
Cancers
·
25
PDF
Prognostic Significance of the Detection of Peripheral Blood CEACAM5mRNA-Positive Cells by Real-Time Polymerase Chain Reaction in Operable Colorectal Cancer
2010
·
Nikolaos Vardakis
, Ippokratis Messaritakis
, et al.
·
Clinical Cancer Research
·
24
Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
2011
·
E Saloustros
, K Kalbakis
, et al.
·
PubMed
·
18
Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma
2021
·
Elena Fountzilas
, Alexia Eliades
, et al.
·
Cancers
·
17
PDF
Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy
2016
·
S Pontikakis
, C Papadaki
, et al.
·
The Pharmacogenomics Journal
·
17
A phase I-II trial of gefitinib in combination with vinorelbine and oxaliplatin as salvage therapy in women with advanced ovarian cancer (AOC)
2004
·
D. Mavroudis
, E. Efstathiou
, et al.
·
Journal of Clinical Oncology
·
15
Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study
2025
·
E. Fountzilas
, S. Karageorgopoulou
, et al.
·
ESMO Real World Data and Digital Oncology
·
11
PDF
PKM2 expression as biomarker for resistance to oxaliplatin-based chemotherapy in colorectal cancer
2019
·
M. Sfakianaki
, C. Papadaki
, et al.
·
Annals of Oncology
·
10
PDF
A Dose Escalation Study of Gemcitabine plus Pemetrexed Administered Biweekly in Patients with Solid Tumors
2006
·
A. Kalykaki
, L. Vamvakas
, et al.
·
Oncology
·
10
Show more works
View as search
Works count:
67
Citation count:
1,808
H-index:
18
I10-index:
25
Year
Topic
Type
